Mark | Date Date | Title Title | |||
---|---|---|---|---|---|
No. 164 | 24 Nov 2023 |
Fast-Track on digital security in health
In response to the increase of cyberattacks in health care settings, the Health Committee of the OECD asked for a paper on Digital Security as part of the OECD ongoing work on health data governance. This working paper emphasizes that as the... |
|||
No. 163 | 21 Nov 2023 |
Examining recent mortality trends
The pandemic resulted in a significant increase in the number of deaths in many OECD countries. With detailed data now available by age and sex, this OECD Health Working Paper examines the trends and differences in mortality patterns over the... |
|||
No. 162 | 31 Oct 2023 |
Understanding international measures of health spending
Assessing health system performance over time or across countries often means comparing populations with very different characteristics, including age structure. The share of the population aged 65 years and over ranges from less than 1 in 10 in some... |
|||
No. 161 | 21 Sept 2023 |
Assessing the future fiscal sustainability of health spending in Ireland
This working paper uses a new method to assess the fiscal sustainability of the Irish health system by considering the effects of population change and income growth on both government revenue and health spending over time.Spending on healthcare is... |
|||
No. 160 | 21 Sept 2023 |
Progress on implementing and using electronic health record systems
Electronic Health Records (eHR) represent a significant digital transformation in the healthcare sector. A 2021 OECD survey of 27 countries revealed a growing adoption of eHRs. However, system fragmentation remains a concern: only 15 countries have a... |
|||
No. 159 | 15 Sept 2023 |
Patient engagement for patient safety
Patients’ and citizens’ perspectives and their active engagement are critical to make health systems safer and people-centred, and are key for co-designing health services and co-producing good health with healthcare professionals, and building trust... |
|||
No. 158 | 27 Jun 2023 |
Value-based payment models in primary care: An assessment of the Menzis Shared Savings programme in the Netherlands
The Menzis Shared Savings Program was initiated in 2014 by the Dutch insurer Menzis and the national primary care organisation Arts en Zorg, and is among the first value-based payment models for primary care in Europe. It runs as a complement to the... |
|||
No. 157 | 09 Aug 2023 |
Developing a set of indicators to monitor the performance of the pharmaceutical industry
The 2018 OECD report Pharmaceutical Innovation and Access to Medicines noted that public debates about pharmaceutical policy are often marked by a lack of authoritative and commonly accepted information supporting the arguments of the stakeholders... |
|||
No. 156 | 09 Jun 2023 |
Enhancing competition in on-patent markets
The 2018 OECD report Pharmaceutical Innovation and Access to Medicines noted that fostering competition in both on- and off-patent markets can improve the efficiency of pharmaceutical spending. Various policies are used to promote competition among... |
|||
No. 155 | 16 Jun 2023 |
Évaluation du programme national de lutte contre le tabagisme en France
Le tabac est responsable de 13% des décès en France et est l'une des principales causes de maladies non transmissibles (MNT), telles que les cancers, les maladies respiratoires et cardiovasculaires. Pour renforcer sa politique de lutte antitabac, la... |
|||
No. 154 | 03 Apr 2023 |
Innovative providers’ payment models for promoting value-based health systems
Innovative providers’ payment models represent an important policy lever that could be used to promote value-based health systems. By bundling services across the continuum of care or to target acute events or chronic conditions, innovative payment... |
|||
No. 153 | 09 Mar 2023 |
Socio-economic and ethnic health inequalities in COVID-19 outcomes across OECD countries
The COVID 19 pandemic has disproportionately hit some vulnerable population groups. Those living in deprived areas, migrant population, and ethnic minorities are at higher risk of catching and dying from the virus than other groups, and they also... |
|||
No. 152 | 27 Feb 2023 |
Improving the timeliness of health expenditure tracking in OECD and low- and middle-income countries
The COVID-19 pandemic has highlighted that access to timely health spending data is crucial for informed policy-making. This Health Working Paper summarises and compares the methodologies applied in around half of OECD countries to estimate public... |
|||
No. 151 | 14 Feb 2023 |
Exploring the feasibility of monitoring access to novel medicines
Ensuring affordable access to novel medicines has been identified as a policy priority among OECD and EU countries, yet systematic monitoring of the various dimensions of access is lacking. Previous efforts to measure access have focused primarily on... |
|||
No. 150 | 03 Feb 2023 |
Advancing patient safety governance in the COVID-19 response
This report examines how patient safety governance mechanisms in OECD countries have withstood the test of COVID-19 and provides recommendations for countries in further improving patient safety governance and strengthening health system resilience. |
|||
No. 149 | 11 Jan 2023 |
All hands on deck: Co-developing the first international survey of people living with chronic conditions
The OECD's Patient-Reported Indicator Surveys (PaRIS) initiative aims to measure outcomes and experiences of healthcare as part of an effort to improve the value of health system investments. The PaRIS survey, a survey of people living with chronic... |
|||
No. 148 | 30 Sept 2022 |
International assessment of the use and results of patient-reported outcome measures for hip and knee replacement surgery
Osteoarthritis impacts 7% of the global population, affecting more than 500 million people worldwide. As populations of OECD countries age, an increasing number of hip and knee replacement surgeries calls for further work on assessment of quality of... |
|||
No. 147 | 14 Sept 2022 |
The economics of medication safety
Poor medication practices and inadequate system infrastructure—resulting in poor adherence, medication-related harms, and medication errors—too often results in patient harm. As many as 1 in 10 hospitalizations in OECD countries may be caused by a... |
|||
No. 146 | 08 Sept 2022 |
Exploring the consequences of greater price transparency on the dynamics of pharmaceutical markets
For some time, governments, stakeholders and civil society have been voicing the need for greater transparency in pharmaceutical pricing. The 2018 OECD report Pharmaceutical Innovation and Access to Medicines suggested that increased price... |
|||
No. 145 | 12 Aug 2022 |
The economics of patient safety
Building on previous OECD Health Working Papers on the economics of patient safety, this paper firstly provides an update on the health burden, and financial and economic cost of unsafe care. It then summarises the evidence on the cost-effectiveness... |
OECD Health Working Papers
English, French
- ISSN: 18152015 (online)
- https://doi.org/10.1787/18152015
1 - 20 of 164 results
Fast-Track on digital security in health
Eric Sutherland, Rishub Keelara, Samuel Eiszele and June Haugrud
24 Nov 2023
In response to the increase of cyberattacks in health care settings, the Health Committee of the OECD asked for a paper on Digital Security as part of the OECD ongoing work on health data governance. This working paper emphasizes that as the...
Examining recent mortality trends
David Morgan, Paul Lukong, Philip Haywood and Gabriel Di Paolantonio
21 Nov 2023
The pandemic resulted in a significant increase in the number of deaths in many OECD countries. With detailed data now available by age and sex, this OECD Health Working Paper examines the trends and differences in mortality patterns over the...
Understanding international measures of health spending
David Morgan and Michael Mueller
31 Oct 2023
Assessing health system performance over time or across countries often means comparing populations with very different characteristics, including age structure. The share of the population aged 65 years and over ranges from less than 1 in 10 in some...
Assessing the future fiscal sustainability of health spending in Ireland
Luca Lorenzoni, Sean Dougherty, Pietrangelo de Biase and Tiago McCarthy
21 Sept 2023
This working paper uses a new method to assess the fiscal sustainability of the Irish health system by considering the effects of population change and income growth on both government revenue and health spending over time.Spending on healthcare is...
Progress on implementing and using electronic health record systems
Luke Slawomirski, Luca Lindner, Katherine de Bienassis, Philip Haywood, Tiago Cravo Oliveira Hashiguchi, Melanie Steentjes and Jillian Oderkirk
21 Sept 2023
Electronic Health Records (eHR) represent a significant digital transformation in the healthcare sector. A 2021 OECD survey of 27 countries revealed a growing adoption of eHRs. However, system fragmentation remains a concern: only 15 countries have a...
Patient engagement for patient safety
Candan Kendir, Rie Fujisawa, Óscar Brito Fernandes, Katherine de Bienassis and Niek Klazinga
15 Sept 2023
Patients’ and citizens’ perspectives and their active engagement are critical to make health systems safer and people-centred, and are key for co-designing health services and co-producing good health with healthcare professionals, and building trust...
Value-based payment models in primary care: An assessment of the Menzis Shared Savings programme in the Netherlands
Luca Lindner and Arthur Hayen
27 Jun 2023
The Menzis Shared Savings Program was initiated in 2014 by the Dutch insurer Menzis and the national primary care organisation Arts en Zorg, and is among the first value-based payment models for primary care in Europe. It runs as a complement to the...
Developing a set of indicators to monitor the performance of the pharmaceutical industry
Rishub Keelara, Martin Wenzl, Lisbeth Waagstein, Marjolijn Moens and Ruth Lopert
09 Aug 2023
The 2018 OECD report Pharmaceutical Innovation and Access to Medicines noted that public debates about pharmaceutical policy are often marked by a lack of authoritative and commonly accepted information supporting the arguments of the stakeholders...
Enhancing competition in on-patent markets
Eliana Barrenho, Marjolijn Moens, Lisbeth Waagstein and Ruth Lopert
09 Jun 2023
The 2018 OECD report Pharmaceutical Innovation and Access to Medicines noted that fostering competition in both on- and off-patent markets can improve the efficiency of pharmaceutical spending. Various policies are used to promote competition among...
Évaluation du programme national de lutte contre le tabagisme en France
Marion Devaux, Alexandra Aldea, Aliénor Lerouge, Marina Dorfmuller Ciampi and Michele Cecchini
16 Jun 2023
Le tabac est responsable de 13% des décès en France et est l'une des principales causes de maladies non transmissibles (MNT), telles que les cancers, les maladies respiratoires et cardiovasculaires. Pour renforcer sa politique de lutte antitabac, la...
Innovative providers’ payment models for promoting value-based health systems
Luca Lindner and Luca Lorenzoni
03 Apr 2023
Innovative providers’ payment models represent an important policy lever that could be used to promote value-based health systems. By bundling services across the continuum of care or to target acute events or chronic conditions, innovative payment...
Socio-economic and ethnic health inequalities in COVID-19 outcomes across OECD countries
Caroline Berchet, José Bijlholt and Mariko Ando
09 Mar 2023
The COVID 19 pandemic has disproportionately hit some vulnerable population groups. Those living in deprived areas, migrant population, and ethnic minorities are at higher risk of catching and dying from the virus than other groups, and they also...
Improving the timeliness of health expenditure tracking in OECD and low- and middle-income countries
Michael Mueller, Fan Xiang, Caroline Penn, Chris James, Luca Lorenzoni and David Morgan
27 Feb 2023
The COVID-19 pandemic has highlighted that access to timely health spending data is crucial for informed policy-making. This Health Working Paper summarises and compares the methodologies applied in around half of OECD countries to estimate public...
Exploring the feasibility of monitoring access to novel medicines
Suzannah Chapman, Anna Szklanowska and Ruth Lopert
14 Feb 2023
Ensuring affordable access to novel medicines has been identified as a policy priority among OECD and EU countries, yet systematic monitoring of the various dimensions of access is lacking. Previous efforts to measure access have focused primarily on...
Advancing patient safety governance in the COVID-19 response
Katherine de Bienassis, Zuzanna Mieloch, Luke Slawomirski and Niek Klazinga
03 Feb 2023
This report examines how patient safety governance mechanisms in OECD countries have withstood the test of COVID-19 and provides recommendations for countries in further improving patient safety governance and strengthening health system resilience.
All hands on deck: Co-developing the first international survey of people living with chronic conditions
Candan Kendir, Rushay Naik, Janika Bloemeke, Katherine de Bienassis, Nicolas Larrain, Niek Klazinga, Frederico Guanais and Michael van den Berg
11 Jan 2023
The OECD's Patient-Reported Indicator Surveys (PaRIS) initiative aims to measure outcomes and experiences of healthcare as part of an effort to improve the value of health system investments. The PaRIS survey, a survey of people living with chronic...
International assessment of the use and results of patient-reported outcome measures for hip and knee replacement surgery
Candan Kendir, Katherine de Bienassis, Luke Slawomirski, Niek Klazinga, Micheline Turnau, Michael Terner, Greg Webster, Eric Bohm, Brian Hallstrom, Ola Rolfson, J. Mark Wilkinson and Anne Lübbeke-Wolff
30 Sept 2022
Osteoarthritis impacts 7% of the global population, affecting more than 500 million people worldwide. As populations of OECD countries age, an increasing number of hip and knee replacement surgeries calls for further work on assessment of quality of...
The economics of medication safety
Katherine de Bienassis, Laura Esmail, Ruth Lopert and Niek Klazinga
14 Sept 2022
Poor medication practices and inadequate system infrastructure—resulting in poor adherence, medication-related harms, and medication errors—too often results in patient harm. As many as 1 in 10 hospitalizations in OECD countries may be caused by a...
Exploring the consequences of greater price transparency on the dynamics of pharmaceutical markets
Eliana Barrenho and Ruth Lopert
08 Sept 2022
For some time, governments, stakeholders and civil society have been voicing the need for greater transparency in pharmaceutical pricing. The 2018 OECD report Pharmaceutical Innovation and Access to Medicines suggested that increased price...
The economics of patient safety
Luke Slawomirski and Niek Klazinga
12 Aug 2022
Building on previous OECD Health Working Papers on the economics of patient safety, this paper firstly provides an update on the health burden, and financial and economic cost of unsafe care. It then summarises the evidence on the cost-effectiveness...